<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JIC</journal-id>
<journal-id journal-id-type="hwp">spjic</journal-id>
<journal-id journal-id-type="nlm-ta">J Intensive Care Med</journal-id>
<journal-title>Journal of Intensive Care Medicine</journal-title>
<issn pub-type="ppub">0885-0666</issn>
<issn pub-type="epub">1525-1489</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0885066610393456</article-id>
<article-id pub-id-type="publisher-id">10.1177_0885066610393456</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Risk Factors and Outcome of Changes in Adrenal Response to ACTH in the Course of Critical Illness</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>de Jong</surname>
<given-names>Margriet Fleur Charlotte</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0885066610393456">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beishuizen</surname>
<given-names>Albertus</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0885066610393456">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Schijndel</surname>
<given-names>Rob Joris Maria Strack</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0885066610393456">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Girbes</surname>
<given-names>Armand Roelof Johan</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0885066610393456">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Groeneveld</surname>
<given-names>Arie Bastiaan Johan</given-names>
</name>
<degrees>MD, PhD, FCCP, FCCM</degrees>
<xref ref-type="aff" rid="aff1-0885066610393456">1</xref>
<xref ref-type="corresp" rid="corresp1-0885066610393456"/>
</contrib>
</contrib-group>
<aff id="aff1-0885066610393456"><label>1</label>Department of Intensive Care and Institute for Cardiovascular Research, Vrije Universiteit medical centre, Amsterdam, The Netherlands</aff>
<author-notes>
<corresp id="corresp1-0885066610393456">Arie Bastiaan Johan Groeneveld, Department of Intensive Care, Vrije Universiteit medical centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Email: <email>johan.groeneveld@vumc.nl</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>1</issue>
<fpage>37</fpage>
<lpage>44</lpage>
<history>
<date date-type="received">
<month>2</month>
<year>2010</year>
</date>
<date date-type="received">
<month>4</month>
<year>2010</year>
</date>
<date date-type="accepted">
<month>4</month>
<year>2010</year>
</date>
</history>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>
<bold>Background.</bold> To evaluate the concept of critical illness-related corticosteroid insufficiency (CIRCI) by studying the clinical significance, in terms of risk factors and outcome, of changes in the cortisol response to repeated adrenocorticotropic hormone (ACTH) testing in the course of critical illness. <bold>Patients and Methods.</bold> In a retrospective study in a medical–surgical intensive care unit (ICU) of a university hospital, we retrospectively included 54 consecutive patients during a 3-year period, who underwent 2 conventional 250 μg ACTH tests at an interval &gt;24 hours, because of ≥6 hours hypotension requiring repeated fluid challenges or vasopressor/inotropic treatment, while corticosteroid treatment was not (yet) initiated. Serum cortisol was measured immediately before and 30 and 60 minutes after intravenous injection of 250 μg of ACTH. Patients were divided into those with an increase (≥0, n = 27) or a decrease (n = 27) in time in delta (Δ) cortisol in response to ACTH and with a Δcortisol &lt;100 (n = 11) and ≥100 nmol/L (n = 43) at the second ACTH test. <bold>Results.</bold> Changes in Δcortisol in time were paralleled by changes in Δcortisol/albumin, with a higher frequency of septic shock, persistently high disease severity, increased renal replacement therapy, and decreased platelet counts in the course of disease with a decrease in Δcortisol in time. Similar trends in increased disease severity were observed when Δcortisol remained or fell to &lt;100 nmol/L. A decrease in Δcortisol between the 2 tests, particularly to &lt;100 nmol/L, was associated with increased mortality (18 nonsurvivors in the ICU). <bold>Conclusions.</bold> The findings favor the concept of dynamic adrenal function rather than poor reproducibility of the ACTH test, so that development of CIRCI, particularly in complicated septic shock and indicated by a fall in Δcortisol (to &lt;100 nmol/L) upon ACTH, correlates to a poor prognosis, independently of baseline cortisol, cortisol binding in blood, and disease severity.</p>
</abstract>
<kwd-group>
<kwd>short ACTH test</kwd>
<kwd>critical illness-related corticosteroid insufficiency</kwd>
<kwd>septic shock</kwd>
<kwd>outcome</kwd>
<kwd>hydrocortisone treatment</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0885066610393456">
<title>Background</title>
<p>Activation of the pituitary–adrenal axis is pivotal in adapting to stress during critical illness.<sup>
<xref ref-type="bibr" rid="bibr1-0885066610393456">1</xref>
<xref ref-type="bibr" rid="bibr2-0885066610393456"/>–<xref ref-type="bibr" rid="bibr3-0885066610393456">3</xref>
</sup> A blunted adrenal corticosteroid response, particularly during sepsis and septic shock, has been termed critical illness-related corticosteroid insufficiency (CIRCI), in which cortisol serum levels, even when supranormal, are considered insufficient for the degree of stress and severity of disease, as manifested by a poor response to additional stimuli.<sup>
<xref ref-type="bibr" rid="bibr2-0885066610393456">2</xref>
<xref ref-type="bibr" rid="bibr3-0885066610393456"/>
<xref ref-type="bibr" rid="bibr4-0885066610393456"/>
<xref ref-type="bibr" rid="bibr5-0885066610393456"/>
<xref ref-type="bibr" rid="bibr6-0885066610393456"/>
<xref ref-type="bibr" rid="bibr7-0885066610393456"/>
<xref ref-type="bibr" rid="bibr8-0885066610393456"/>
<xref ref-type="bibr" rid="bibr9-0885066610393456"/>
<xref ref-type="bibr" rid="bibr10-0885066610393456"/>
<xref ref-type="bibr" rid="bibr11-0885066610393456"/>
<xref ref-type="bibr" rid="bibr12-0885066610393456"/>
<xref ref-type="bibr" rid="bibr13-0885066610393456"/>
<xref ref-type="bibr" rid="bibr14-0885066610393456"/>
<xref ref-type="bibr" rid="bibr15-0885066610393456"/>–<xref ref-type="bibr" rid="bibr16-0885066610393456">16</xref>
</sup> The standard 250 μg adrenocorticotropic hormone (ACTH) stimulation test may help to evaluate CIRCI during sepsis and shock when the cortisol response to ACTH is subnormal, for instance &lt;250<sup>
<xref ref-type="bibr" rid="bibr2-0885066610393456">2</xref>,<xref ref-type="bibr" rid="bibr11-0885066610393456">11</xref>
</sup> or, as we found, 100 nmol/L,<sup>
<xref ref-type="bibr" rid="bibr15-0885066610393456">15</xref>
</sup> even when the baseline cortisol levels are high. Critical illness-related corticosteroid insufficiency may be independently associated with mortality that may be attenuated by corticosteroid therapy.<sup>
<xref ref-type="bibr" rid="bibr2-0885066610393456">2</xref>
<xref ref-type="bibr" rid="bibr3-0885066610393456"/>
<xref ref-type="bibr" rid="bibr4-0885066610393456"/>
<xref ref-type="bibr" rid="bibr5-0885066610393456"/>
<xref ref-type="bibr" rid="bibr6-0885066610393456"/>
<xref ref-type="bibr" rid="bibr7-0885066610393456"/>
<xref ref-type="bibr" rid="bibr8-0885066610393456"/>
<xref ref-type="bibr" rid="bibr9-0885066610393456"/>
<xref ref-type="bibr" rid="bibr10-0885066610393456"/>
<xref ref-type="bibr" rid="bibr11-0885066610393456"/>
<xref ref-type="bibr" rid="bibr12-0885066610393456"/>
<xref ref-type="bibr" rid="bibr13-0885066610393456"/>
<xref ref-type="bibr" rid="bibr14-0885066610393456"/>
<xref ref-type="bibr" rid="bibr15-0885066610393456"/>–<xref ref-type="bibr" rid="bibr16-0885066610393456">16</xref>
</sup> Risk factors for a diminished cortisol response supportive for the concept of CIRCI in transversal studies, including ours, are use of etomidate, severe disease as expressed by scoring systems, and low platelet counts, among others.<sup>
<xref ref-type="bibr" rid="bibr16-0885066610393456">16</xref>,<xref ref-type="bibr" rid="bibr17-0885066610393456">17</xref>
</sup> However, the concept of CIRCI, even in sepsis and shock, has been challenged because of, among others, uncertainties in cortisol cutoff levels in the ACTH test, potential dependency of the increase in baseline cortisol and circulating cortisol-binding proteins, poor reproducibility of the test, its predictive value for mortality, and benefit of corticosteroid treatment.<sup>
<xref ref-type="bibr" rid="bibr2-0885066610393456">2</xref>,<xref ref-type="bibr" rid="bibr3-0885066610393456">3</xref>,<xref ref-type="bibr" rid="bibr7-0885066610393456">7</xref>,<xref ref-type="bibr" rid="bibr9-0885066610393456">9</xref>,<xref ref-type="bibr" rid="bibr10-0885066610393456">10</xref>,<xref ref-type="bibr" rid="bibr12-0885066610393456">12</xref><xref ref-type="bibr" rid="bibr13-0885066610393456"/>–<xref ref-type="bibr" rid="bibr14-0885066610393456">14</xref>,<xref ref-type="bibr" rid="bibr16-0885066610393456">16</xref>,<xref ref-type="bibr" rid="bibr18-0885066610393456">18</xref><xref ref-type="bibr" rid="bibr19-0885066610393456"/><xref ref-type="bibr" rid="bibr20-0885066610393456"/><xref ref-type="bibr" rid="bibr21-0885066610393456"/>–<xref ref-type="bibr" rid="bibr22-0885066610393456">22</xref></sup> The recent multicenter CORTICUS study suggests that, overall, a low response to ACTH predicts neither shock reversal nor attenuation of mortality by corticosteroid therapy in septic shock.<sup>
<xref ref-type="bibr" rid="bibr20-0885066610393456">20</xref>
</sup> This study was heavily criticized, however.<sup>
<xref ref-type="bibr" rid="bibr23-0885066610393456">23</xref>
</sup> These factors have fuelled the ongoing controversy on the value of the ACTH test in patients at risk of CIRCI in order to decide on the administration of corticosteroids, so that ACTH testing is currently not recommended.<sup>
<xref ref-type="bibr" rid="bibr23-0885066610393456">23</xref>,<xref ref-type="bibr" rid="bibr24-0885066610393456">24</xref>
</sup>
</p>
<p>Longitudinal observations in individual patients, evaluating clinical correlates, if any, of changes in cortisol responses in time may help solving the controversy on CIRCI and the value of the ACTH test in its evaluation. Briegel et al<sup>
<xref ref-type="bibr" rid="bibr4-0885066610393456">4</xref>
</sup> and Ho et al<sup>
<xref ref-type="bibr" rid="bibr12-0885066610393456">12</xref>
</sup> noted that a subnormal (total) cortisol response to ACTH had normalized in many patients upon recovery from septic shock, suggesting septic shock-induced but reversible CIRCI. Goodman et al,<sup>
<xref ref-type="bibr" rid="bibr7-0885066610393456">7</xref>
</sup> however, noted poor predictive values in the results of repeated ACTH testing, during septic shock. Guzman et al<sup>
<xref ref-type="bibr" rid="bibr25-0885066610393456">25</xref>
</sup> suggested adrenal exhaustion during septic shock, thereby decreasing the cortisol response to ACTH in time and enhancing the predictive value for a hemodynamic benefit of corticosteroid treatment. Wu et al<sup>
<xref ref-type="bibr" rid="bibr26-0885066610393456">26</xref>
</sup> showed that prolonged critical illness was often associated with a decrease in serum cortisol, although no responses to ACTH were measured. Marik<sup>
<xref ref-type="bibr" rid="bibr27-0885066610393456">27</xref>
</sup> showed that CIRCI can develop in persistently hemodynamically unstable patients during admission in the intensive care unit (ICU).</p>
<p>In view of these controversies, we wished to evaluate the risk factors and outcome of dynamic changes in cortisol responses to ACTH in the critically ill and performed a retrospective longitudinal cohort study in 54 consecutive patients in whom 2 ACTH tests at a &gt;24-hour interval were performed in the course of their intensive care stay. We hypothesized that a fall in the cortisol response to ACTH, particularly to &lt;100 nmol/L, in the course of disease is associated with increasing incidence of risk factors for CIRCI, with an increased mortality, as found in transversal studies on critically ill patients,<sup>
<xref ref-type="bibr" rid="bibr15-0885066610393456">15</xref>,<xref ref-type="bibr" rid="bibr17-0885066610393456">17</xref>
</sup> rather than reflecting poor reproducibility of the test.<sup>
<xref ref-type="bibr" rid="bibr18-0885066610393456">18</xref>
</sup> We included albumin levels in the analysis to take into account cortisol binding in blood.<sup>
<xref ref-type="bibr" rid="bibr12-0885066610393456">12</xref>,<xref ref-type="bibr" rid="bibr22-0885066610393456">22</xref>
</sup>
</p>
</sec>
<sec id="section2-0885066610393456">
<title>Patients and Methods</title>
<sec id="section3-0885066610393456">
<title>Study Population and ACTH Test</title>
<p>Informed consent was waived, because the ACTH test was performed on clinical and not on investigational grounds. The Dutch legislation does not require informed consent for retrospective studies, provided results are treated anonymously. We retrospectively included all consecutive patients admitted to the 28-bed ICU of our university hospital in a 3-year period, who underwent 2 or more short ACTH (tetracosactide-hexa-acetate, Synacthen, Novartis Pharma, Basel, Switzerland) stimulation tests for clinical reasons during ICU admission with an interval of at least 24 hours. Of the patients who underwent 3 ACTH tests, the test results of the second and third tests were used for analysis. Patients with known abnormalities of the hypothalamic-pituitary-adrenal axis were excluded, but patients with low baseline cortisol values were not excluded, since there were no validated reference values for primary adrenal insufficiency in the critically ill.</p>
<p>Adrenocorticotropic hormone testing was performed in any patient suspected to have CIRCI, because of ≥6-hour hypotension (&lt;100 mm Hg systolic) requiring repeated fluid challenges or prolonged vasopressor/inotropic treatment, in the absence of treatment by corticosteroids. Blood samples for serum cortisol measurements were taken immediately before (T = 0) and at T = 30 and T = 60 minutes after intravenous injection of 250 μg of synthetic ACTH. The highest value of T = 30 or T = 60 for peak response and its increase, absolutely and relatively to baseline values (Δcortisol and Δcortisol%) was taken. Cortisol was measured by competitive immunoassay (ASC-180 System, Bayer Diagnostics, Netherlands). The coefficient of variation of this measurement is 3% for the intra- and 6% for the interassay variation, and the detection limit is 30 nmol/L (500 nmol/L = 18 μg/dL). Baseline cortisol levels of at least 165 nmol/L, peak responses to ACTH &gt;500 to 550 nmol/L, and increases in cortisol &gt;200 to 250 nmol/L are considered normal, although ACTH-induced increases &lt;100 nmol/L appeared the optimal cutoff to define CIRCI in our previous study.<sup>
<xref ref-type="bibr" rid="bibr6-0885066610393456">6</xref>,<xref ref-type="bibr" rid="bibr16-0885066610393456">16</xref>
</sup> The decision to administer hydrocortisone (starting at 100 mg intravenously, every 8 hours) was taken on clinical grounds by the attending intensivist, awaiting ACTH test results. If the test was considered normal, hydrocortisone, when started, was discontinued, if possible, on clinical grounds. Dexamethasone administration for reasons other than (suspected) CIRCI, such as chronic pulmonary obstructive disease, was recorded. Etomidate was frequently used in our institution for intubation. No patient was treated by ketoconazole.</p>
</sec>
<sec id="section4-0885066610393456">
<title>Data Collection</title>
<p>Patients were divided in those with an increase or decrease in Δcortisol over the 2 tests. Cortisol/albumin ratios were calculated as an indicator of free cortisol. The single patient with an unchanged Δcortisol was included in the group with a Δcortisol increase. General characteristics including age, gender, type, and reason of admission and underlying diseases were recorded. Severity of disease was assessed by calculation of the Simplified Acute Physiology Score II (SAPS II, 0-163),<sup>
<xref ref-type="bibr" rid="bibr28-0885066610393456">28</xref>
</sup> and the Sequential Organ Failure Assessment score (SOFA, 0-24),<sup>
<xref ref-type="bibr" rid="bibr29-0885066610393456">29</xref>
</sup> both at admission and at the day of ACTH testing, including hemodynamic, pulmonary, renal, neurological, infectious, and biochemical parameters. The worst values within a 24-hour time frame were used to calculate the scores. Missing values were regarded as normal. Multiple organ dysfunction was defined by a SOFA ≥7. Interventions including type and doses of vasopressor/inotropes, intubation, use of etomidate, and need for mechanical ventilation and renal replacement therapy were recorded. In addition, culture results from blood, tracheal aspirate, urine, or other local site from 7 days before ACTH testing to the day of testing were collected. After the day of testing, the following data were recorded: start and duration of treatment with corticosteroids (hydrocortisone or dexamethasone), outcome until day 28 of ICU stay, outcome in the ICU, length of ICU stay, and hospital mortality. Systemic inflammatory response syndrome (SIRS) was defined as 2 or more of the following criteria: a temperature &gt;38°C or &lt;35.5°C, a leukocyte count &gt;12 or &lt;4 × 10<sup>
<xref ref-type="bibr" rid="bibr9-0885066610393456">9</xref>
</sup>/L, a heart rate &gt;90/min, and a respiratory rate &gt;20/min or the presence of mechanical ventilation. Sepsis at the ACTH test day was defined as the presence of SIRS with a positive microbiological local (urine, trachea, or other) and/or blood culture. By virtue of study criteria, septic patients are those with septic shock.</p>
</sec>
<sec id="section5-0885066610393456">
<title>Statistical Analysis</title>
<p>In comparing groups, the Fisher exact test was used for categorical variables. We used generalized estimating equations to evaluate the association of Δcortisol (≥ or &lt;100 nmol/L) changes with study variables on ACTH test days, taking repeated measurements in time, that is, second versus first test, into account, and to multivariably predict Δcortisol changes by risk factors found in univariable analyses. Continuous data were analyzed after logarithmic conversion to normalize distributions, where appropriate. The nonparametric Spearman rank correlation coefficient was calculated to express relations between variables. Kaplan-Meier curves were made and a log rank test was performed to evaluate the effect of Δcortisol changes (to &lt;100 nmol/L) on survival duration, taking disease severity into account. Data are expressed as median (range). A 2-sided <italic>P</italic> ≤ .05 was considered to indicate statistical significance and exact <italic>P</italic> values are given, unless &lt;.001.</p>
</sec>
</sec>
<sec id="section6-0885066610393456">
<title>Results</title>
<sec id="section7-0885066610393456">
<title>Patient Characteristics</title>
<p>In the study period, 3953 patients were admitted to the ICU of whom 458 underwent an ACTH test once and 54 patients twice or more. <xref ref-type="table" rid="table1-0885066610393456">Table 1</xref>
 shows the clinical characteristics of these 54 patients, at ICU admission according to temporal changes in Δcortisol upon ACTH and a persistent or fall to &lt;100 nmol/L.</p>
<table-wrap id="table1-0885066610393456" position="float">
<label>Table 1.</label>
<caption>
<p>Patient Characteristics at ICU Admission and Outcome<sup>
<xref ref-type="table-fn" rid="table-fn2-0885066610393456">a</xref>
</sup>
</p>
</caption>
<graphic alternate-form-of="table1-0885066610393456" xlink:href="10.1177_0885066610393456-table1.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">
</th>
<th rowspan="2">Increase in ΔCortisol (n = 27)</th>
<th rowspan="2">Decrease in ΔCortisol (n = 27)</th>
<th colspan="2">Test 2</th>
<th rowspan="2">
<italic>P</italic>
</th>
</tr>
<tr>
<th>≥100 nmol/L (n = 43)</th>
<th>&lt;100 nmol/L (n = 11)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gender, m/f</td>
<td>18 (67)/9 (33)</td>
<td>18 (67)/9 (33)</td>
<td>25 (58)/18 (42)</td>
<td>11 (100)/0</td>
<td>.010</td>
</tr>
<tr>
<td>Age, years</td>
<td>65 (33-78)</td>
<td>67 (18-92)</td>
<td>65 (18-92)</td>
<td>73 (37-84)</td>
<td>
</td>
</tr>
<tr>
<td colspan="6">Underlying disease</td>
</tr>
<tr>
<td> Cardiovascular</td>
<td>14 (52)</td>
<td>15 (56)</td>
<td>21 (49)</td>
<td>8 (73)</td>
<td>
</td>
</tr>
<tr>
<td> Renal</td>
<td>0</td>
<td>1 (4)</td>
<td>1 (2)</td>
<td>0</td>
<td>
</td>
</tr>
<tr>
<td> Pulmonary</td>
<td>2 (7)</td>
<td>1 (4)</td>
<td>3 (7)</td>
<td>0</td>
<td>
</td>
</tr>
<tr>
<td> Gastrointestinal</td>
<td>2 (7)</td>
<td>2 (7)</td>
<td>4 (9)</td>
<td>0</td>
<td>
</td>
</tr>
<tr>
<td> Neurological</td>
<td>1 (4)</td>
<td>1 (4)</td>
<td>2 (5)</td>
<td>0</td>
<td>
</td>
</tr>
<tr>
<td> Endocrinological</td>
<td>3 (11)</td>
<td>3 (11)</td>
<td>5 (12)</td>
<td>1 (9)</td>
<td>
</td>
</tr>
<tr>
<td> Malignancy</td>
<td>2 (7)</td>
<td>2 (7)</td>
<td>2 (5)</td>
<td>2 (19)</td>
<td>
</td>
</tr>
<tr>
<td colspan="6">Admission syndromes<sup>
<xref ref-type="table-fn" rid="table-fn3-0885066610393456">b</xref>
</sup>
</td>
</tr>
<tr>
<td> Trauma/postoperative</td>
<td>14 (52)</td>
<td>13 (48)</td>
<td>22 (51)</td>
<td>5 (45)</td>
<td>
</td>
</tr>
<tr>
<td> Heart surgery</td>
<td>6 (22)</td>
<td>6 (22)</td>
<td>10 (23)</td>
<td>2 (18)</td>
<td>
</td>
</tr>
<tr>
<td> Vascular surgery</td>
<td>4 (15)</td>
<td>2 (7)</td>
<td>4 (9)</td>
<td>2 (18)</td>
<td>
</td>
</tr>
<tr>
<td> Respiratory failure</td>
<td>7 (26)</td>
<td>7 (26)</td>
<td>11 (26)</td>
<td>3 (27)</td>
<td>
</td>
</tr>
<tr>
<td> Post-CPR</td>
<td>2 (7)</td>
<td>2 (7)</td>
<td>4 (9)</td>
<td>0</td>
<td>
</td>
</tr>
<tr>
<td> Shock</td>
<td>1 (4)</td>
<td>2 (7)</td>
<td>2 (5)</td>
<td>1 (9)</td>
<td>
</td>
</tr>
<tr>
<td> Sepsis</td>
<td>4 (15)</td>
<td>4 (15)</td>
<td>5 (12)</td>
<td>3 (27)</td>
<td>
</td>
</tr>
<tr>
<td> Renal insufficiency</td>
<td>1 (4)</td>
<td>2 (7)</td>
<td>2 (5)</td>
<td>1 (9)</td>
<td>
</td>
</tr>
<tr>
<td> Other</td>
<td>3 (11)</td>
<td>3 (11)</td>
<td>5 (12)</td>
<td>2 (18)</td>
<td>
</td>
</tr>
<tr>
<td>Admission SAPS II</td>
<td>35 (9-66)</td>
<td>42 (16-82)</td>
<td>34 (9-69)</td>
<td>56 (30-82)</td>
<td>.002</td>
</tr>
<tr>
<td>Admission SOFA</td>
<td>8 (1-18)</td>
<td>8 (4-15)</td>
<td>7 (1-14)</td>
<td>9 (6-18)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Prior corticosteroid treatment</td>
<td>7 (26)</td>
<td>5 (19)</td>
<td>10 (23)</td>
<td>2 (18)</td>
<td>
</td>
</tr>
<tr>
<td>Prior etomidate</td>
<td>6 (22)</td>
<td>5 (19)</td>
<td>9 (21)</td>
<td>2 (18)</td>
<td>
</td>
</tr>
<tr>
<td>Length of stay, days</td>
<td>48 (3-190)</td>
<td>35 (7-109)</td>
<td>45 (3-190)</td>
<td>37 (10-113)</td>
<td>.039<sup>
<xref ref-type="table-fn" rid="table-fn4-0885066610393456">c</xref>
</sup>
</td>
</tr>
<tr>
<td>Mortality until day 28</td>
<td>0</td>
<td>5 (19)</td>
<td>3 (7)</td>
<td>2 (18)</td>
<td>.051<sup>
<xref ref-type="table-fn" rid="table-fn4-0885066610393456">c</xref>
</sup>
</td>
</tr>
<tr>
<td>ICU mortality</td>
<td>6 (22)</td>
<td>12 (44)</td>
<td>11 (26)</td>
<td>7 (64)</td>
<td>.029</td>
</tr>
<tr>
<td>Hospital mortality</td>
<td>10 (37)</td>
<td>12 (44)</td>
<td>15 (35)</td>
<td>8 (73)</td>
<td>.039</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0885066610393456">
<p>Abbreviations: ICU, intensive care unit; CPR, cardiopulmonary resuscitaton; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment; ACTH, adrenocorticotropic hormone.</p>
</fn>
<fn id="table-fn2-0885066610393456">
<p>
<sup>a</sup> Median (range) or number (%), where appropriate; patients were classified when the cortisol response to ACTH was increasing/similar, or decreasing, or similar in the course of disease.</p>
</fn>
<fn id="table-fn3-0885066610393456">
<p>
<sup>b</sup> Patients may have more than 1 condition; exact <italic>P</italic> values ≤.05.</p>
</fn>
<fn id="table-fn4-0885066610393456">
<p>
<sup>c</sup> For increase/decrease in ΔCortisol</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section8-0885066610393456">
<title>ΔCortisol and Risk Factors</title>
<p>
<xref ref-type="table" rid="table2-0885066610393456">Table 2</xref>
 shows that an increase or a decrease in Δcortisol in time (in 47 [87%] of 54 patients) was paralleled by directionally similar changes in Δcortisol divided by albumin and independent of baseline cortisol (/albumin) levels, even though the change in Δcortisol inversely related to change in baseline values (<italic>r</italic>
<sub>s</sub> = −.43, <italic>P</italic> = .001). The Δcortisol directly related to albumin levels (<italic>r</italic>
<sub>s</sub> = .37, <italic>P</italic> &lt; .001) but changes in time did not.</p>
<table-wrap id="table2-0885066610393456" position="float">
<label>Table 2.</label>
<caption>
<p>Variables According to Changes in ACTH-Induced ΔCortisol in Time<sup>
<xref ref-type="table-fn" rid="table-fn6-0885066610393456">a</xref>
</sup>
</p>
</caption>
<graphic alternate-form-of="table2-0885066610393456" xlink:href="10.1177_0885066610393456-table2.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">
</th>
<th colspan="2">Increase in ΔCortisol (n = 27)</th>
<th colspan="2">Decrease in ΔCortisol (n = 27)</th>
<th rowspan="2">
<italic>P</italic>
</th>
</tr>
<tr>
<th>First Test</th>
<th>Second Test</th>
<th>First Test</th>
<th>Second Test</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="6">ACTH test and corticosteroids</td>
</tr>
<tr>
<td> Days from admission to test</td>
<td>6 (1-37)</td>
<td>34 (2-92)</td>
<td>5 (1-37)</td>
<td>15 (5-85)</td>
<td>.005</td>
</tr>
<tr>
<td> Albumin, g/L</td>
<td>13 (7-32)</td>
<td>16 (6-23)</td>
<td>13 (6-23)</td>
<td>12 (3-24)</td>
<td>
</td>
</tr>
<tr>
<td> Baseline cortisol, nmol/L</td>
<td>400 (30-1010)</td>
<td>340 (40-1160)</td>
<td>330 (74-630)</td>
<td>355 (125-965)</td>
<td>
</td>
</tr>
<tr>
<td> Baseline cortisol/albumin, nmol/g</td>
<td>32 (1-53)</td>
<td>26 (2-61)</td>
<td>26 (5-57)</td>
<td>34 (7-197)</td>
<td>
</td>
</tr>
<tr>
<td> Δcortisol, nmol/L</td>
<td>165 (−20-420)</td>
<td>285 (4-825)</td>
<td>245 (90-505)</td>
<td>155 (−407-400)</td>
<td align="center">na</td>
</tr>
<tr>
<td> Δcortisol, %</td>
<td>34 (−3-210)</td>
<td>78 (10-207)</td>
<td>78 (21-386)</td>
<td>42 (−89-296)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> Δcortisol &lt;100 nmol/L</td>
<td>8 (30)</td>
<td>3 (11)</td>
<td>1 (4)</td>
<td>8 (30)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> Δcortisol &lt;250 nmol/L</td>
<td>19 (70)</td>
<td>11 (41)</td>
<td>14 (52)</td>
<td>20 (74)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> Δcortisol/albumin, nmol/g</td>
<td>12 (0-34)</td>
<td>21 (0-42)</td>
<td>20 (9-51)</td>
<td>13 (-58-43)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> Peak cortisol, nmol/L</td>
<td>620 (30-1280)</td>
<td>585 (44-1620)</td>
<td>590 (230-1030)</td>
<td>500 (235-1030)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> Start corticosteroids</td>
<td>18 (67)</td>
<td>19 (70)</td>
<td>12 (44)</td>
<td>24 (89)</td>
<td>.007</td>
</tr>
<tr>
<td> Start hydrocortisone</td>
<td>16 (59)</td>
<td>17 (63)</td>
<td>7 (26)</td>
<td>23 (85)</td>
<td>.048</td>
</tr>
<tr>
<td> Duration, days</td>
<td>21 (1-44)</td>
<td>11 (4-154)</td>
<td>13 (3-32)</td>
<td>12 (1-39)</td>
<td>
</td>
</tr>
<tr>
<td> Start dexamethasone</td>
<td>2 (7)</td>
<td>1 (4)</td>
<td>5 (19)</td>
<td>1 (4)</td>
<td>
</td>
</tr>
<tr>
<td colspan="6">Infection</td>
</tr>
<tr>
<td> SIRS on test day</td>
<td>24 (89)</td>
<td>17 (63)</td>
<td>22 (81)</td>
<td>20 (74)</td>
<td>.001</td>
</tr>
<tr>
<td> Septic shock on test day</td>
<td>23 (85)</td>
<td>15 (56)</td>
<td>20 (74)</td>
<td>19 (70)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> ICU-acquired septic shock</td>
<td>17 (74)</td>
<td>15 (100)</td>
<td>16 (80)</td>
<td>19 (100)</td>
<td>
</td>
</tr>
<tr>
<td colspan="6"> Causative microorganism<sup>
<xref ref-type="table-fn" rid="table-fn7-0885066610393456">b</xref>
</sup>
</td>
</tr>
<tr>
<td>  Enterobacteriaceae</td>
<td>15 (56)</td>
<td>12 (80)</td>
<td>15 (75)</td>
<td>17 (89)</td>
<td>
</td>
</tr>
<tr>
<td>  Nonfermenting Gram rods</td>
<td>9 (39)</td>
<td>11 (73)</td>
<td>7 (35)</td>
<td>12 (63)</td>
<td>
</td>
</tr>
<tr>
<td>  Staphylococci</td>
<td>8 (30)</td>
<td>6 (40)</td>
<td>10 (50)</td>
<td>11 (58)</td>
<td>
</td>
</tr>
<tr>
<td>  Anaerobic gram+ cocci</td>
<td>7 (30)</td>
<td>6 (40)</td>
<td>6 (30)</td>
<td>5 (26)</td>
<td>
</td>
</tr>
<tr>
<td>  Yeasts and fungi</td>
<td>10 (43)</td>
<td>10 (67)</td>
<td>7 (35)</td>
<td>9 (47)</td>
<td>
</td>
</tr>
<tr>
<td>  Others</td>
<td>3 (11)</td>
<td>1 (7)</td>
<td>4 (20)</td>
<td>1 (5)</td>
<td>
</td>
</tr>
<tr>
<td> Bacteremia</td>
<td>7 (26)</td>
<td>3 (11)</td>
<td>4 (15)</td>
<td>7 (26)</td>
<td>
</td>
</tr>
<tr>
<td> Positive culture of tracheal aspirate</td>
<td>23 (85)</td>
<td>19 (70)</td>
<td>15 (56)</td>
<td>16 (59)</td>
<td>.001</td>
</tr>
<tr>
<td> Positive other local culture</td>
<td>12 (44)</td>
<td>12 (44)</td>
<td>16 (59)</td>
<td>19 (70)</td>
<td>
</td>
</tr>
<tr>
<td> Temperature,°C</td>
<td>37.6 (33.4-38.8)</td>
<td>37.2 (36.0-39.7)</td>
<td>37.7 (35.0-39.4)</td>
<td>37.1 (36.1-39.2)</td>
<td>
</td>
</tr>
<tr>
<td> Leukocytes, ×10<sup>9</sup>/L</td>
<td>11.2 (1.9-24.2)</td>
<td>10.8 (2.6-17.5)</td>
<td>12.3 (3.9-32.8)</td>
<td>14.3 (5.8-23.8)</td>
<td>
</td>
</tr>
<tr>
<td> Platelets, ×10<sup>9</sup>/L</td>
<td>130 (32-481)</td>
<td>204 (25-906)</td>
<td>173 (40-818)</td>
<td>258 (20-463)</td>
<td>.012</td>
</tr>
<tr>
<td colspan="6">Disease severity</td>
</tr>
<tr>
<td> MAP, mm Hg</td>
<td>74 (55-107)</td>
<td>73 (45-90)</td>
<td>73 (48-93)</td>
<td>69 (54-108)</td>
<td>
</td>
</tr>
<tr>
<td> Vasopressors/inotropes</td>
<td>23 (85)</td>
<td>22 (81)</td>
<td>24 (89)</td>
<td>24 (89)</td>
<td>
</td>
</tr>
<tr>
<td> Mechanical ventilation</td>
<td>26 (96)</td>
<td>25 (93)</td>
<td>25 (93)</td>
<td>23 (85)</td>
<td>.034</td>
</tr>
<tr>
<td> Renal replacement therapy</td>
<td>7 (26)</td>
<td>1 (4)</td>
<td>10 (37)</td>
<td>8 (30)</td>
<td>.037</td>
</tr>
<tr>
<td> Arterial pH</td>
<td>7.40 (7.14-7.49)</td>
<td>7.44 (7.22-7.53)</td>
<td>7.41 (7.15-7.50)</td>
<td>7.44 (7.05-7.53)</td>
<td>
</td>
</tr>
<tr>
<td> Bicarbonate, mmol/L</td>
<td>23.7 (14.2-32.1)</td>
<td>26.0 (18.0-33.1)</td>
<td>21.7 (12.5-35.2)</td>
<td>26.1 (6.9-33.2)</td>
<td>
</td>
</tr>
<tr>
<td> SAPS II</td>
<td>41 (13-70)</td>
<td>36 (10-55)</td>
<td>40 (12-64)</td>
<td>39 (17-81)</td>
<td>.010</td>
</tr>
<tr>
<td> SOFA</td>
<td>10 (4-18)</td>
<td>7 (1-18)</td>
<td>9 (4-16)</td>
<td>8 (2-17)</td>
<td>.002</td>
</tr>
<tr>
<td> Multiple organ dysfunction</td>
<td>22 (81)</td>
<td>17 (63)</td>
<td>20 (74)</td>
<td>19 (70)</td>
<td>.049</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0885066610393456">
<p>Abbreviations: ICU, intensive care unit; MAP, mean arterial pressure; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment; na, not applicable; SIRS, systemic inflammatory response syndrome.</p>
</fn>
<fn id="table-fn6-0885066610393456">
<p>
<sup>a</sup> Median (range) or number (%), where appropriate. Patients were classified when the cortisol response to ACTH was increasing/similar, or decreasing, or similar in the course of disease.</p>
</fn>
<fn id="table-fn7-0885066610393456">
<p>
<sup>b</sup> Patients may have more than one; exact <italic>P</italic> values &lt;0.05. <italic>P</italic> value refers to the association of Δcortisol (≥ or &lt;100 nmol/L) changes with study variables on ACTH test days, taking repeated measurements in time, that is, second versus first test, into account.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Overall disease severity, expressed by SAPS II and SOFA scores, decreased in patients with an increase in Δcortisol in time, but not in patients with a decrease in Δcortisol. The Δcortisol changes inversely related to changes in SAPS II and SOFA scores (minimum <italic>r</italic>
<sub>s</sub> = −.31, <italic>P</italic> = .022). Other risk factors for a decrease in Δcortisol in time included increasing frequency of SIRS, septic shock, and renal replacement therapy, relatively low increase in platelet counts, whereas the need for mechanical ventilation and positivity of tracheal aspirate cultures decreased.</p>
<p>In patients with an increase in Δcortisol to ≥100 nmol/L, the SAPS II and SOFA scores decreased, in comparison with patients with a decrease in Δcortisol to &lt;100 nmol/L (<xref ref-type="table" rid="table3-0885066610393456">Table 3</xref>
). The latter had an increased positivity of cultures from tracheal aspirates and decreased platelet counts. Use of etomidate was similar whether Δcortisol increased or decreased (<xref ref-type="table" rid="table1-0885066610393456">Table 1</xref>). Therapy with corticosteroids inversely followed changes in Δcortisol (to &lt;100 nmol/L).</p>
<table-wrap id="table3-0885066610393456" position="float">
<label>Table 3.</label>
<caption>
<p>Variables According to 100 nmol/L Cutoff for ΔCortisol at Second ACTH Test<sup>
<xref ref-type="table-fn" rid="table-fn9-0885066610393456">a</xref>
</sup>
</p>
</caption>
<graphic alternate-form-of="table3-0885066610393456" xlink:href="10.1177_0885066610393456-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th colspan="2">Test 2, ≥100 nmol/L (n = 43)</th>
<th colspan="2">&lt;100 nmol/L (n = 11)</th>
<th>
<italic>
</italic>
</th>
</tr>
<tr>
<th>
</th>
<th>First Test</th>
<th>Second Test</th>
<th>First Test</th>
<th>Second Test</th>
<th>P</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="6">ACTH test and corticosteroids</td>
</tr>
<tr>
<td> Days from admission to test</td>
<td>6 (1-37)</td>
<td>18 (2-85)</td>
<td>6 (1-37)</td>
<td>22 (5-92)</td>
<td>
</td>
</tr>
<tr>
<td> Albumin, g/L</td>
<td>13 (6-32)</td>
<td>15 (5-23)</td>
<td>15 (6-26)</td>
<td>8 (3-24)</td>
<td>
</td>
</tr>
<tr>
<td> Baseline cortisol, nmol/L</td>
<td>370 (110-1010)</td>
<td>340 (125-1160)</td>
<td>325 (30-630)</td>
<td>355 (40-965)</td>
<td>
</td>
</tr>
<tr>
<td> Baseline cortisol/albumin, nmol/g</td>
<td>31 (5-53)</td>
<td>26 (7-62)</td>
<td>27 (1-57)</td>
<td>43 (2-197)</td>
<td>
</td>
</tr>
<tr>
<td> ΔCortisol, nmol/L</td>
<td>240 (−20-505)</td>
<td>260 (100-825)</td>
<td>120 (0-425)</td>
<td>50 (−407-95)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> ΔCortisol, %</td>
<td>63 (−3-386)</td>
<td>74 (24-296)</td>
<td>31 (0-380)</td>
<td>11 (−89-79)</td>
<td>.003</td>
</tr>
<tr>
<td> ΔCortisol &lt;100 nmol/L</td>
<td>5 (12)</td>
<td>na</td>
<td>4 (36)</td>
<td>na</td>
<td>
</td>
</tr>
<tr>
<td> ΔCortisol &lt;250 nmol/L</td>
<td>24 (56)</td>
<td>20 (47)</td>
<td>9 (82)</td>
<td>11 (100)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> ΔCortisol/albumin, nmol/g</td>
<td>18 (0-51)</td>
<td>19 (1-43)</td>
<td>11 (0-26)</td>
<td>4 (−58-13)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> Peak cortisol, nmol/L</td>
<td>625 (300-1280)</td>
<td>540 (295-1620)</td>
<td>415 (30-970)</td>
<td>410 (44-1030)</td>
<td>.015</td>
</tr>
<tr>
<td> Start corticosteroids</td>
<td>24 (56)</td>
<td>32 (74)</td>
<td>6 (55)</td>
<td>11 (100)</td>
<td>.013</td>
</tr>
<tr>
<td> Start hydrocortisone</td>
<td>19 (37)</td>
<td>30 (70)</td>
<td>4 (37)</td>
<td>10 (91)</td>
<td>.018</td>
</tr>
<tr>
<td> Duration, d</td>
<td>17 (1-42)</td>
<td>11 (3-154)</td>
<td>17 (4-44)</td>
<td>17 (1-39)</td>
<td>
</td>
</tr>
<tr>
<td> Start dexamethasone</td>
<td>5 (12)</td>
<td>2 (5)</td>
<td>2 (18)</td>
<td>0</td>
<td>
</td>
</tr>
<tr>
<td colspan="6">Infection</td>
</tr>
<tr>
<td> SIRS on test day</td>
<td>36 (84)</td>
<td>28 (65)</td>
<td>10 (91)</td>
<td>9 (82)</td>
<td>
</td>
</tr>
<tr>
<td> Septic shock on test day</td>
<td>35 (81)</td>
<td>25 (58)</td>
<td>8 (73)</td>
<td>9 (82)</td>
<td>
</td>
</tr>
<tr>
<td> ICU-acquired septic shock</td>
<td>26 (74)</td>
<td>25 (100)</td>
<td>7 (88)</td>
<td>9 (100)</td>
<td>
</td>
</tr>
<tr>
<td> Causative microorganism<sup>
<xref ref-type="table-fn" rid="table-fn10-0885066610393456">b</xref>
</sup>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>  Enterobacteriaceae</td>
<td>23 (53)</td>
<td>20 (47)</td>
<td>7 (64)</td>
<td>9 (82)</td>
<td>
</td>
</tr>
<tr>
<td>  Nonfermenting Gram rods</td>
<td>14 (33)</td>
<td>21 (49)</td>
<td>2 (18)</td>
<td>2 (18)</td>
<td>
</td>
</tr>
<tr>
<td>  Staphylococci</td>
<td>13 (30)</td>
<td>13 (30)</td>
<td>5 (45)</td>
<td>4 (36)</td>
<td>
</td>
</tr>
<tr>
<td>  Anaerobic gram+ cocci</td>
<td>12 (28)</td>
<td>9 (21)</td>
<td>1 (9)</td>
<td>2 (18)</td>
<td>
</td>
</tr>
<tr>
<td>  Yeasts and fungi</td>
<td>14 (33)</td>
<td>16 (37)</td>
<td>3 (27)</td>
<td>3 (27)</td>
<td>
</td>
</tr>
<tr>
<td>  Others</td>
<td>6 (14)</td>
<td>2 (5)</td>
<td>1 (9)</td>
<td>0</td>
<td>
</td>
</tr>
<tr>
<td> Bacteremia</td>
<td>10 (23)</td>
<td>8 (19)</td>
<td>1 (9)</td>
<td>2 (18)</td>
<td>
</td>
</tr>
<tr>
<td> Positive culture of tracheal aspirate</td>
<td>29 (67)</td>
<td>26 (60)</td>
<td>9 (82)</td>
<td>9 (82)</td>
<td>.059</td>
</tr>
<tr>
<td> Positive other local culture</td>
<td>22 (51)</td>
<td>24 (56)</td>
<td>6 (55)</td>
<td>7 (64)</td>
<td>
</td>
</tr>
<tr>
<td> Temperature, °C</td>
<td>37.6 (33.4-39.4)</td>
<td>37.3 (36.0-39.7)</td>
<td>37.7 (35.7-38.6)</td>
<td>36.8 (36.4-38.5)</td>
<td>
</td>
</tr>
<tr>
<td> Leukocytes, ×10<sup>9</sup>/L</td>
<td>11.4 (1.9-32.8)</td>
<td>11.4 (2.6-23.8)</td>
<td>12.6 (3.9-19.0)</td>
<td>12.9 (4.8-23.7)</td>
<td>
</td>
</tr>
<tr>
<td> Platelets, ×10<sup>9</sup>/L</td>
<td>160 (32-818)</td>
<td>249 (20-296)</td>
<td>88 (40-397)</td>
<td>68 (25-398)</td>
<td>.029</td>
</tr>
<tr>
<td colspan="6">Disease severity</td>
</tr>
<tr>
<td> MAP, mm Hg</td>
<td>74 (48-107)</td>
<td>73 (45-108)</td>
<td>77 (63-83)</td>
<td>63 (53-87)</td>
<td>
</td>
</tr>
<tr>
<td> Vasopressors/inotropes</td>
<td>37 (86)</td>
<td>36 (84)</td>
<td>10 (91)</td>
<td>10 (91)</td>
<td>
</td>
</tr>
<tr>
<td> Mechanical ventilation</td>
<td>40 (93)</td>
<td>37 (86)</td>
<td>11 (100)</td>
<td>11 (100)</td>
<td>
</td>
</tr>
<tr>
<td> Renal replacement therapy</td>
<td>12 (28)</td>
<td>4 (9)</td>
<td>5 (45)</td>
<td>5 (45)</td>
<td>
</td>
</tr>
<tr>
<td> Arterial pH</td>
<td>7.40 (7.15-7.50)</td>
<td>7.44 (7.05-7.53)</td>
<td>7.41 (7.14-7.45)</td>
<td>7.41 (7.25-7.53)</td>
<td>
</td>
</tr>
<tr>
<td> Bicarbonate, mmol/L</td>
<td>23.3 (12.5-35.2)</td>
<td>26.5 (6.9-33.2)</td>
<td>21.7 (14.2-32.1)</td>
<td>25.6 (14.9-33.1)</td>
<td>
</td>
</tr>
<tr>
<td> SAPS II</td>
<td>38 (12-70)</td>
<td>33 (10-65)</td>
<td>52 (24-64)</td>
<td>47 (24-81)</td>
<td>.003</td>
</tr>
<tr>
<td> SOFA</td>
<td>9 (4-16)</td>
<td>7 (1-13)</td>
<td>13 (4-18)</td>
<td>10 (4-18)</td>
<td>.005</td>
</tr>
<tr>
<td> Multiple organ dysfunction</td>
<td>32 (74)</td>
<td>26 (60)</td>
<td>10 (91)</td>
<td>10(91)</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8-0885066610393456">
<p>Abbreviations: SIRS: systemic inflammatory response syndrome; ICU: intensive care unit; MAP: mean arterial pressure; SAPS II: Simplified Acute Physiology Score II; SOFA: Sequential Organ Failure Assessment; na: not applicable.</p>
</fn>
<fn id="table-fn9-0885066610393456">
<p>
<sup>a</sup> Median (range). 500 nmol/L = 18 μg/dL cortisol. Median (range) or number (%), where appropriate.</p>
</fn>
<fn id="table-fn10-0885066610393456">
<p>
<sup>b</sup> Patients may have more than 1. Exact <italic>P</italic> values ≤.05. <italic>P</italic> value refers to the association of Δcortisol (≥ or &lt;100 nmol/L) changes with study variables on ACTH test days, taking repeated measurements in time, that is, second versus first test, into account.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section9-0885066610393456">
<title>Outcome and Risk Factors</title>
<p>The ICU mortality rate was 33% and mortality until day 28 was 9%; hospital mortality was 43%. All nonsurvivors before day 28 had a decrease in Δcortisol, that carried a mortality of 19% versus 0% if Δcortisol increased (<xref ref-type="table" rid="table1-0885066610393456">Table 1</xref>; <xref ref-type="fig" rid="fig1-0885066610393456">Figure 1</xref>
). Intensive care unit and hospital mortality was higher in patients with a persistent or fall in Δcortisol to &lt;100 nmol/L. Intensive care unit mortality was, in univariate analyses, predicted by a fall in albumin (<italic>P</italic> = .009), a fall in Δcortisol (<italic>P</italic> = .020), a fall in body temperature (<italic>P</italic> = .048), a rise in need for renal replacement therapy (<italic>P</italic> = .031), and rising SAPS II and SOFA scores (<italic>P</italic> = .015 or less). Corticosteroid treatment after the first test was associated with an increased survival duration until day 28 (<italic>P</italic> = .006).</p>
<fig id="fig1-0885066610393456" position="float">
<label>Figure 1.</label>
<caption>
<p>Kaplan-Meier curves for survival duration in the hospital for Δcortisol change in repeated ACTH testing. A, Upper line increase in Δcortisol, lower line decrease in Δcortisol (<italic>P</italic> = .006 log rank test for survival duration in ICU; <italic>P</italic> = .022 in hospital). B, In strata around median SAPS II score at first test (log rank <italic>P</italic> = .005 in ICU, <italic>P</italic> = .012 in hospital). ↑ and ↓ indicate increase and decrease in Δcortisol, respectively; vertical lines, censored data; ACTH, adrenocorticotropic hormone; ICU, intensive care unit; SAPS II, Simplified Acute Physiology Score II.</p>
</caption>
<graphic alternate-form-of="fig1-0885066610393456" xlink:href="10.1177_0885066610393456-fig1.tif"/>
</fig>
</sec>
<sec id="section10-0885066610393456">
<title>Multivariable Analyses</title>
<p>In multivariable modeling of risk factors, a decrease in Δcortisol in time was independent of each other predicted by persistent septic shock (<italic>P</italic> = .007), a decrease in albumin (<italic>P</italic> = .018), and a rise in SAPS II (<italic>P</italic> = .008). A persistent fall in Δcortisol to &lt;100 nmol/L was predicted by increasing SOFA score (<italic>P</italic> = .006) together with increasingly positive cultures of tracheal aspirates (<italic>P</italic> = .034). Intensive care unit mortality was predicted by a fall in Δcortisol (<italic>P</italic> = .045) and by SAPS II or SOFA score at first test (<italic>P</italic> = .010), whereas changes in disease severity and treatment by corticosteroids did not contribute. <xref ref-type="fig" rid="fig1-0885066610393456">Figure 1</xref> shows that the predictive value of Δcortisol for outcome in the course of time was indeed independent of SAPS II score.</p>
</sec>
</sec>
<sec id="section11-0885066610393456">
<title>Discussion</title>
<p>Our observational longitudinal retrospective data suggest that an increase in the cortisol response to ACTH testing during the course of critical illness reflects reversible CIRCI, independently of baseline cortisol levels and cortisol binding in blood, and associated with improving septic shock, disease severity, and survival. Conversely, developing or worsening CIRCI may be associated with persistent and complicated septic shock, high disease severity, and ultimate mortality, in spite of treatment by corticosteroids. Collectively, these data argue against poor reproducibility of the ACTH test as the single factor affecting dynamic changes of test results in the course of disease.</p>
<p>The findings agree with the idea that septic shock and severe disease are major determinants, as shown in transversal analyses,<sup>
<xref ref-type="bibr" rid="bibr15-0885066610393456">15</xref>,<xref ref-type="bibr" rid="bibr17-0885066610393456">17</xref>
</sup> of a diminished response of cortisol to ACTH in critical illness and associated mortality. Specifically, our longitudinal study also agrees with the transversal data that renal replacement therapy and low platelet counts are risk factors for a fall in Δcortisol.<sup>
<xref ref-type="bibr" rid="bibr17-0885066610393456">17</xref>
</sup> Although both may be complications of septic shock, low platelets may be associated with adrenal thrombosis and/or hemorrhage directly causing dysfunction. In contrast, metabolic acidosis<sup>
<xref ref-type="bibr" rid="bibr17-0885066610393456">17</xref>
</sup> did not appear as a risk factor in the current study. Thus, the change in cortisol response to ACTH in time during critical illness is not likely caused by poor reproducibility, altered baseline levels, or cortisol binding in blood, but primarily by varying dynamic adrenal function and, often septic shock-induced, CIRCI. Indeed, Marik<sup>
<xref ref-type="bibr" rid="bibr27-0885066610393456">27</xref>
</sup> showed that adrenal function in the critically ill is a dynamic process. Patients with an increase in Δcortisol in time retained adrenal responsiveness and therefore resolved their septic shock. However, our retrospective study cannot decide whether the prolonged septic shock caused the adrenal exhaustion or the adrenal exhaustion contributed to the septic shock, but the absence of a dear survival benefit of treatment by corticosteroids after the second test and a decrease in Δcortisol in time independently being predicted by persistent septic shock and a rise in disease severity suggest the former. Thus, in our patients, the prolonged septic shock and severe disease could have caused adrenal exhaustion and CIRCI. On the other hand, the presence of septic shock at first and second ACTH test was often overlapping, so that it is hard to conclude on varying severity of the same or different septic episodes. The use of etomidate did not affect the course of Δcortisol in our patients, probably because the negative effect of etomidate on adrenal cortisol synthesis may be reversible within 24 to 72 hours,<sup>
<xref ref-type="bibr" rid="bibr16-0885066610393456">16</xref>
</sup> which is shorter than the median interval between admission, often directly followed by intubation and start of mechanical ventilation, and ACTH tests in our study. The (limited) retrospective data do not suggest that treatment by corticosteroids was most beneficial in improving survival, when given in septic shock patients with a low Δcortisol (to &lt;100 nmol/L), as noted in our previous study.<sup>
<xref ref-type="bibr" rid="bibr15-0885066610393456">15</xref>
</sup> Nevertheless, the association of corticosteroid therapy after the first ACTH test with survival, is in agreement with the idea that the potential benefit of corticosteroid treatment in sepsis and shock is due to treatment (and thereby perhaps reversibility) of CIRCI. Our data roughly agree with the study performed by Briegel et al<sup>
<xref ref-type="bibr" rid="bibr4-0885066610393456">4</xref>
</sup> who noted that normalization of subnormal cortisol responses to ACTH in patients who survived septic shock had occurred at a mean of 30 days after onset.</p>
<p>The concept of CIRCI during sepsis and shock has been criticized because of, among others, poor predictive values of ACTH test results for the attenuating effect of corticosteroid treatment on vasopressor dependency and mortality, as claimed by others.<sup>
<xref ref-type="bibr" rid="bibr2-0885066610393456">2</xref>
<xref ref-type="bibr" rid="bibr3-0885066610393456"/>
<xref ref-type="bibr" rid="bibr4-0885066610393456"/>
<xref ref-type="bibr" rid="bibr5-0885066610393456"/>
<xref ref-type="bibr" rid="bibr6-0885066610393456"/>
<xref ref-type="bibr" rid="bibr7-0885066610393456"/>
<xref ref-type="bibr" rid="bibr8-0885066610393456"/>
<xref ref-type="bibr" rid="bibr9-0885066610393456"/>
<xref ref-type="bibr" rid="bibr10-0885066610393456"/>
<xref ref-type="bibr" rid="bibr11-0885066610393456"/>
<xref ref-type="bibr" rid="bibr12-0885066610393456"/>
<xref ref-type="bibr" rid="bibr13-0885066610393456"/>
<xref ref-type="bibr" rid="bibr14-0885066610393456"/>
<xref ref-type="bibr" rid="bibr15-0885066610393456"/>–<xref ref-type="bibr" rid="bibr16-0885066610393456">16</xref>,<xref ref-type="bibr" rid="bibr19-0885066610393456">19</xref>
</sup> Furthermore, the recent multicenter CORTICUS trial<sup>
<xref ref-type="bibr" rid="bibr20-0885066610393456">20</xref>
</sup> does not seem to corroborate the latter findings, so that the controversy in this regard remains unresolved. However, the CORTICUS trial<sup>
<xref ref-type="bibr" rid="bibr20-0885066610393456">20</xref>
</sup> can be heavily criticized.<sup>
<xref ref-type="bibr" rid="bibr23-0885066610393456">23</xref>
</sup> Nevertheless, our study showing the clinical significance of dynamic changes in Δcortisol during critical illness using repeated ACTH testing, independent of baseline cortisol levels and cortisol binding in blood, may help resolve the ongoing controversy on the concept of CIRCI and design future studies.</p>
<p>Our study has certain limitations, apart from relatively low numbers and the retrospective design. Cortisol-binding globulin (CBG) and free cortisol levels were not measured in our study, and we may, thus, have underestimated the baseline free cortisol levels and rises upon ACTH from total cortisol levels.<sup>
<xref ref-type="bibr" rid="bibr12-0885066610393456">12</xref>,<xref ref-type="bibr" rid="bibr14-0885066610393456">14</xref>,<xref ref-type="bibr" rid="bibr19-0885066610393456">19</xref>,<xref ref-type="bibr" rid="bibr21-0885066610393456">21</xref>,<xref ref-type="bibr" rid="bibr22-0885066610393456">22</xref>
</sup> However, we used albumin levels to estimate free cortisol, since albumin binds cortisol, although less than CBG, and albumin and CBG levels may behave similarly in critical illness.<sup>
<xref ref-type="bibr" rid="bibr12-0885066610393456">12</xref>,<xref ref-type="bibr" rid="bibr14-0885066610393456">14</xref>,<xref ref-type="bibr" rid="bibr19-0885066610393456">19</xref>,<xref ref-type="bibr" rid="bibr21-0885066610393456">21</xref>,<xref ref-type="bibr" rid="bibr22-0885066610393456">22</xref>
</sup> The changes in total cortisol were paralleled by changes in estimated free cortisol upon ACTH in our study, as in others,<sup>
<xref ref-type="bibr" rid="bibr12-0885066610393456">12</xref>
</sup> even though the increase in total cortisol upon ACTH was relatively low when albumin levels were low.</p>
</sec>
<sec id="section12-0885066610393456">
<title>Conclusion</title>
<p>By showing clinical correlates, our repeated ACTH test results favor the concept of dynamic adrenal function rather than poor reproducibility of the ACTH test, so that development of CIRCI, particularly in complicated septic shock and indicated by a fall in Δcortisol (to &lt;100 nmol/L) upon ACTH related in our small series to a poor outcome, independently of baseline cortisol, cortisol binding in blood, and disease severity. Prospective trials, however, may be needed to confirm these concepts.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn12-0885066610393456">
<p>The author(s) declared no conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn13-0885066610393456">
<p>The author(s) received no financial support for the research and/or authorship of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0885066610393456">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorin</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Qualls</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Crapo</surname>
<given-names>LM.</given-names></name></person-group> <article-title>Diagnosis of adrenal insufficiency</article-title>. <source>Ann Intern Med</source>. <year>2003</year>;<volume>139</volume>(<issue>3</issue>):<fpage>194</fpage>–<lpage>204</lpage>.</citation>
</ref>
<ref id="bibr2-0885066610393456">
<label>2</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>De Jong</surname>
<given-names>MFC</given-names>
</name>
<name>
<surname>Beishuizen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Groeneveld</surname>
<given-names>ABJ</given-names>
</name>
</person-group>
<article-title>Defining relative adrenal insufficiency in the critically ill: the ACTH test revisited</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Vincent</surname>
<given-names>JL</given-names>
</name>
</person-group> (Ed.), <source>Yearbook of Intensive Care and Emergency Medicine 2006</source>.<year>2006</year>;<publisher-loc>Berlin, Germany</publisher-loc>: <publisher-name>Springer Verlag</publisher-name>, <fpage>539</fpage>–<lpage>552</lpage>.</citation>
</ref>
<ref id="bibr3-0885066610393456">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marik</surname>
<given-names>PE.</given-names></name></person-group> <article-title>Mechanisms and clinical consequences of critical illness associated adrenal insufficiency</article-title>. <source>Curr Opin Crit Care</source>. <year>2007</year>;<volume>13</volume>(<issue>4</issue>):<fpage>363</fpage>–<lpage>369</lpage>.</citation>
</ref>
<ref id="bibr4-0885066610393456">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Briegel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schelling</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mraz</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Forst</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Peter</surname>
<given-names>K.</given-names></name></person-group> <article-title>A comparison of the adrenocortical response during septic shock and after complete recovery</article-title>. <source>Intensive Care Med</source>. <year>1996</year>;<volume>22</volume>(<issue>9</issue>):<fpage>894</fpage>–<lpage>899</lpage>.</citation>
</ref>
<ref id="bibr5-0885066610393456">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Annane</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sébille</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Troché</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Raphaël</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Gajdos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bellissant</surname>
<given-names>E.</given-names></name></person-group> <article-title>A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin</article-title>. <source>JAMA</source>. <year>2000</year>;<volume>283</volume>(<issue>8</issue>):<fpage>1038</fpage>–<lpage>1045</lpage>.</citation>
</ref>
<ref id="bibr6-0885066610393456">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bollaert</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Fieux</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Charpentier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>B.</given-names></name></person-group> <article-title>Baseline cortisol levels, cortisol response to corticotropin, and prognosis in late septic shock</article-title>. <source>Shock</source>. <year>2003</year>;<volume>19</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr7-0885066610393456">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sprung</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>YG.</given-names></name></person-group> <article-title>Cortisol changes among patients with septic shock and the relationship to ICU and hospital stay</article-title>. <source>Intensive Care Med</source>. <year>2005</year>;<volume>31</volume>(<issue>10</issue>):<fpage>1362</fpage>–<lpage>1369</lpage>.</citation>
</ref>
<ref id="bibr8-0885066610393456">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oppert</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schindler</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Husung</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock</article-title>. <source>Crit Care Med</source>. <year>2005</year>;<volume>33</volume>(<issue>11</issue>):<fpage>2457</fpage>–<lpage>2464</lpage>.</citation>
</ref>
<ref id="bibr9-0885066610393456">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rady</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Helmers</surname>
<given-names>R.</given-names></name></person-group> <article-title>Cortisol levels and corticosteroid administration fail to predict mortality in critical illness: the confounding effects of organ dysfunction and sex</article-title>. <source>Arch Surg</source>. <year>2005</year>;<volume>140</volume>(<issue>7</issue>):<fpage>661</fpage>–<lpage>668</lpage>.</citation>
</ref>
<ref id="bibr10-0885066610393456">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siraux</surname>
<given-names>V</given-names>
</name>
<name>
<surname>De Backer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yalavatti</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests</article-title>. <source>Crit Care Med</source>. <year>2005</year>;<volume>33</volume>(<issue>11</issue>):<fpage>2479</fpage>–<lpage>2486</lpage>.</citation>
</ref>
<ref id="bibr11-0885066610393456">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Annane</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Maxime</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Boudou</surname>
<given-names>P.</given-names></name></person-group> <article-title>Diagnosis of adrenal insufficiency in severe sepsis and septic shock</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2006</year>;<volume>174</volume>(<issue>12</issue>):<fpage>1319</fpage>–<lpage>1326</lpage>.</citation>
</ref>
<ref id="bibr12-0885066610393456">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Al-Musalhi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>MJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Septic shock and sepsis: a comparison of total and free plasma cortisol levels</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2006</year>;<volume>91</volume>(<issue>1</issue>):<fpage>105</fpage>–<lpage>114</lpage>.</citation>
</ref>
<ref id="bibr13-0885066610393456">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Venet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Donati</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy</article-title>. <source>Intensive Care Med</source>. <year>2006</year>;<volume>32</volume>(<issue>8</issue>):<fpage>1184</fpage>–<lpage>1190</lpage>.</citation>
</ref>
<ref id="bibr14-0885066610393456">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salgado</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Verdeal</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Rocco</surname>
<given-names>JR.</given-names></name></person-group> <article-title>Adrenal function testing in patients with septic shock</article-title>. <source>Crit Care</source>. <year>2006</year>;<volume>10</volume>(<issue>5</issue>):<fpage>R149</fpage>.</citation>
</ref>
<ref id="bibr15-0885066610393456">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Jong</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Beishuizen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Spijkstra</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Groeneveld</surname>
<given-names>AB.</given-names></name></person-group> <article-title>Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock</article-title>. <source>Crit Care Med</source>. <year>2007</year>;<volume>35</volume>(<issue>8</issue>):<fpage>1896</fpage>–<lpage>1903</lpage>.</citation>
</ref>
<ref id="bibr16-0885066610393456">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipiner-Friedman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sprung</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Lattere</surname>
<given-names>PF</given-names>
</name>
<etal/>
</person-group>. <article-title>Adrenal function in sepsis: the retrospective Corticus cohort study</article-title>. <source>Crit Care Med</source>. <year>2007</year>;<volume>35</volume>(<issue>4</issue>):<fpage>1012</fpage>–<lpage>1018</lpage>.</citation>
</ref>
<ref id="bibr17-0885066610393456">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Jong</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Beishuizen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Spijkstra</surname>
<given-names>JJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Predicting a low cortisol response to adrenocorticotrophic hormone in the critically ill: a retrospective cohort study</article-title>. <source>Crit Care</source>. <year>2007</year>;<volume>11</volume>(<issue>3</issue>):<fpage>R61</fpage>.</citation>
</ref>
<ref id="bibr18-0885066610393456">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loisa</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Uusaro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ruokonen</surname>
<given-names>E.</given-names></name></person-group> <article-title>A single adrenocorticotropic hormone stimulation test does not reveal adrenal insufficiency in septic shock</article-title>. <source>Anesth Analg</source>. <year>2005</year>;<volume>101</volume>(<issue>6</issue>):<fpage>1792</fpage>–<lpage>1798</lpage>.</citation>
</ref>
<ref id="bibr19-0885066610393456">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arafah</surname>
<given-names>BM.</given-names></name></person-group> <article-title>Review: hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2006</year>;<volume>91</volume>(<issue>10</issue>):<fpage>3725</fpage>–<lpage>3745</lpage>.</citation>
</ref>
<ref id="bibr20-0885066610393456">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sprung</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Annane</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Keh</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrocortisone therapy for patients with septic shock</article-title>. <source>N Engl J Med</source>. <year>2008</year>;<volume>358</volume>(<issue>2</issue>):<fpage>111</fpage>–<lpage>124</lpage>.</citation>
</ref>
<ref id="bibr21-0885066610393456">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beishuizen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thijs</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Vermes</surname>
<given-names>I.</given-names></name></person-group> <article-title>Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma</article-title>. <source>Intensive Care Med</source>. <year>2001</year>;<volume>27</volume>(<issue>10</issue>):<fpage>1584</fpage>–<lpage>1591</lpage>.</citation>
</ref>
<ref id="bibr22-0885066610393456">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamrahian</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Oseni</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Arafah</surname>
<given-names>BM.</given-names></name></person-group> <article-title>Measurements of serum free cortisol in critically ill patients</article-title>. <source>N Engl J Med</source>. <year>2004</year>;<volume>350</volume>(<issue>16</issue>):<fpage>1629</fpage>–<lpage>1638</lpage>.</citation>
</ref>
<ref id="bibr23-0885066610393456">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groeneveld</surname>
<given-names>ABJ</given-names>
</name>
<name>
<surname>Molenaar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Beishuizen</surname>
<given-names>A.</given-names></name></person-group> <article-title>Should we abandon corticosteroids during septic shock? No</article-title>. <source>Curr Opin Crit Care</source>. <year>2008</year>;<volume>14</volume>(<issue>4</issue>):<fpage>384</fpage>–<lpage>389</lpage>.</citation>
</ref>
<ref id="bibr24-0885066610393456">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dellinger</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Karlet</surname>
<given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008</article-title>. <source>Crit Care Med</source>. <year>2008</year>;<volume>36</volume>(<issue>1</issue>):<fpage>296</fpage>–<lpage>327</lpage>.</citation>
</ref>
<ref id="bibr25-0885066610393456">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guzman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Guzman</surname>
<given-names>CB.</given-names></name></person-group> <article-title>Adrenal exhaustion in septic patients with vasopressor dependency</article-title>. <source>J Crit Care</source>. <year>2007</year>;<volume>22</volume>(<issue>4</issue>):<fpage>319</fpage>–<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr26-0885066610393456">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J-Y</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>S-C</given-names>
</name>
<name>
<surname>Ku</surname>
<given-names>S-C</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>C-C</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C-J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P-C.</given-names></name></person-group> <article-title>Adrenal insufficiency in prolonged critical illness</article-title>. <source>Crit Care</source>. <year>2008</year>;<volume>12</volume>(<issue>3</issue>):<fpage>R65</fpage>.</citation>
</ref>
<ref id="bibr27-0885066610393456">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marik</surname>
<given-names>PE.</given-names></name></person-group> <article-title>Adrenal-exhaustion syndrome in patients with liver disease</article-title>. <source>Intensive Care Med</source>. <year>2006</year>;<volume>32</volume>(<issue>2</issue>):<fpage>275</fpage>–<lpage>279</lpage>.</citation>
</ref>
<ref id="bibr28-0885066610393456">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Gall</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lemeshow</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saulnier</surname>
<given-names>F.</given-names></name></person-group> <article-title>A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study</article-title>. <source>JAMA</source>. <year>1993</year>;<volume>270</volume>(<issue>24</issue>):<fpage>2957</fpage>–<lpage>2963</lpage>.</citation>
</ref>
<ref id="bibr29-0885066610393456">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Peres Bota</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bross</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mélot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>JL.</given-names></name></person-group> <article-title>Serial evaluation of the SOFA score to predict outcome in critically ill patients</article-title>. <source>JAMA</source>. <year>2001</year>;<volume>286</volume>(<issue>14</issue>):<fpage>1754</fpage>–<lpage>1758</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>